Who Paid My Doc
Joel Rosh
Pediatric Gastroenterology Morristown, NJ Medical Doctor
NPI 1326011255 CMS profile 240960
100 Madison Avenue, Morristown, NJ 07960
General payments
$20,926
Research payments
$5,618
Ownership & investment interest
$0
Research they led as principal investigator
$320,522
Through program year 2025, Joel Rosh of Morristown, NJ is reported in the CMS Open Payments database as having received $20,926 across 61 general payments and $5,618 in research payments paid to them. Separately, studies naming them as principal investigator received $320,522 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 93rd percentile of Pediatric Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,650 | 2 | |
| 2024 | General | $4,583 | 3 | |
| 2023 | General | $5,953 | 4 | |
| 2022 | General | $1,768 | 11 | |
| 2021 | General | $5,388 | 16 | |
| 2021 | Research | $4,564 | 3 | |
| 2020 | General | $110 | 7 | |
| 2020 | Research | $563 | 1 | |
| 2019 | General | $1,474 | 18 | |
| 2019 | Research | $492 | 1 |
Beside peers
- Joel Rosh
- Pediatric Gastroenterology median
- Middle half of Pediatric Gastroenterology
- National median
In program year 2025, general payments to Joel Rosh were reported at $1,650. Among 1,132 Pediatric Gastroenterology profiles paid that year, the median was $194 and the middle half received between $81 and $540.
Show as a table
| Year | Joel Rosh | Pediatric Gastroenterology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,474 | $131 | $41–$311 | $163 |
| 2020 | $110 | $79 | $23–$223 | $114 |
| 2021 | $5,388 | $104 | $32–$321 | $132 |
| 2022 | $1,768 | $125 | $37–$331 | $149 |
| 2023 | $5,953 | $169 | $55–$440 | $160 |
| 2024 | $4,583 | $196 | $73–$563 | $164 |
| 2025 | $1,650 | $194 | $81–$540 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
66 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Gastroenterology in New Jersey
Rupinder Gill
Pediatric Gastroenterology · New Brunswick, NJ
Alycia Leiby
Pediatric Gastroenterology · Morristown, NJ
John Tung
Pediatric Gastroenterology · Camden, NJ
Oren Koslowe
Pediatric Gastroenterology · Morristown, NJ
Svetlana Sabel
Pediatric Gastroenterology · West Orange, NJ
Alexander Schosheim
Pediatric Gastroenterology · Ocean, NJ
Related records
Pediatric Gastroenterology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Gastroenterology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.